Please login to the form below
PharmaLex
This page shows the latest PharmaLex news and features for those working in and with pharma, biotech and healthcare.
PharmaLex announces joint venture with Vintura
We are very excited to be joining forces with the PharmaLex Group," said Gérard Klop, partner at Vintura. ... In addition, the international footprint of PharmaLex supports our international growth objectives," he added.
Latest news
-
PharmaLex expands its footprint to Italy
The consultancy opens new office in Milan. Development consulting and affairs group PharmaLex has expanded its operations to Italy, opening a new office in Milan. ... Acting as a base for PharmaLex Italy, the new location will be headed by regulatory
-
PharmaLex strikes up AI collaboration with Volv
The duo will develop pharmacovigilance products and services. Development consulting and affairs group PharmaLex has teamed up with privately held Volv Global to bolster its pharmacovigilance business. ... Dr Thomas Dobmeyer, chief executive officer of
-
PharmaLex expands with new Paris office
Dr Thomas Dobmeyer, co-chief executive officer of PharmaLex, said: “For the pharmaceutical industry, France plays a significant role on an international level. ... Guillaume commented: “Together with Patrick Larcier, I am excited to have planted the
-
Alapis acquires Pharmalex for USD 19.5m
Greece-headquartered Pharmalex is not operational at the moment but previously ran production and distribution activities in the region. ... The Pharmalex purchase is the latest in a raft of buy ups across central and southern Europe.
More from news
Approximately 4 fully matching, plus 1 partially matching documents found.
Latest Intelligence
-
Brexit Means Brexit
EU27 markets,” says Jonathan Trethowan, VP, Regulatory and Scientific Policy, PharmaLex.
More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.
Latest appointments
-
PharmaLex strengthens international team
Consultancy group appoints Adrian Pencak. PharmaLex Group has appointed new executive vice president, business development and marketing in the form of Adrian Pencak. ... Dr Thomas Dobmeyer, chief executive officer at PharmaLex, said: “Adrian’s
-
PharmaLex appoints Dr Adam King to its regulatory team
PharmaLex has appointed Dr Adam King as its senior director, regulatory affairs and service area, a role that will see him work on regulatory activities related to mergers and acquisitions. ... He said: “I am excited to be part of the PharmaLex team
-
PharmaLex appoints Zabin Younes as associate director
She joins from ERA Consulting. Development consulting and scientific affairs firm PharmaLex Group has expanded its regulatory team with the addition of Zabin Younes. ... Zabin comes to us with a wealth of experience,” said Dr Thomas Dobmeyer, CEO of
-
PharmaLex Group strengthens development consulting team
Friedrichsdorf, Germany-based PharmaLex Group has bolstered its development consulting division with the appointments of Carolyn Belcher and Lutz Wevelsiep. ... Belcher (pictured right) joins PharmaLex as executive vice president of development
More from appointments
Approximately 4 fully matching, plus 0 partially matching documents found.
Latest from PMHub
-
PharmaLex - Confidence beyond Compliance
PharmaLex is one of the largest global specialized providers of Development Consulting, Regulatory Affairs, Quality Management &Compliance and Pharmacovigilance, Epidemiology &Risk Management worldwide. ... PharmaLex - Confidence beyond Compliance.
More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.
COVID-19 Updates and Daily News
Featured jobs
- How will the events and exhibitions industry change post-Coronavirus?
- New study identifies drugs that are safe to use in COVID-19 treatment
- Keytruda doubles five-year survival rate in NSCLC
- Novavax starts first phase 3 COVID-19 vaccine trial in the UK
- Novacyt launches diagnostic test to differentiate between COVID-19 and flu
- Relief Therapeutics seeks US emergency approval for COVID-19 drug
PMHub
Nucleus Global
Nucleus Global is the largest specialist medical communications network in the world. Globally, we have over 700 experts delivering world-class...
Latest intelligence
- Switzerland: a life sciences hub
- Switzerland has a rich diversity of pharma and biotech companies that sustain activity and help maintain its reputation as a highly innovative country...
- Responding to dynamic shifts in value communications
- OPEN Health’s Beth Lesher and Annemarie Clegg examine what the convergence of medical communications and market access means for pharmaceutical companies....
- Doing what we can and having fun doing it: our fundraising month
- Charities are facing a number of challenges just to stay afloat amidst the current COVID-19 pandemic. Fundraisers are being cancelled and public donations are not as abundant as they have...
Quick links
Infographics
